Recent advances in the diagnosis and management of Takayasu arteritis complicated with ocular ischemic syndrome_Chinese Journal of Ocular Fundus Diseases

Authors：

Zeng Yue ,  Zhang Meixia

Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu 610041, China;

Corresponding author：

Zhang Meixia, Email: meixiazhang@foxmail.com

Keywords：

Review; Takayasu arteritis; Ocular ischemic syndrome

DOI：

10.3760/cma.j.cn511434-20200902-00428

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Takayasu arteritis (TA) is a rare, chronic non-specific vasculitis that can lead to ocular hypoperfusion. As a result, ocular ischemic syndrome (OIS), which prominently manifests as Takayasu retinopathy, may develop subsequently. Ocular manifestations mainly consist of progressive painless vision loss and amaurosis fugax in TA patients complicated with OIS. However, due to the lack of specific clinical characteristics, it is of great significance to improve the timely diagnosis aided by multimodal imaging, especially fundus fluorescein angiography. Early diagnosis of OIS is essential for reversal of ocular ischemia and better prognosis of TA patients. Management of OIS patients associated with Takayasu arteritis requires a combination of systemic and ophthalmic treatment. Therefore, the optimal individualized regiment should be determined by disease activity and progression, which are addressed by multi-disciplinary team assessment. Ophthalmologists should further understand the clinical features and the importance of regular ophthalmologic examinations during the disease course, thus to improve the overall survival and visual outcomes.

Citation： Zeng Yue, Zhang Meixia. Recent advances in the diagnosis and management of Takayasu arteritis complicated with ocular ischemic syndrome. Chinese Journal of Ocular Fundus Diseases, 2021, 37(9): 743-747. doi: 10.3760/cma.j.cn511434-20200902-00428 Copy

1.	Numano F. The story of Takayasu arteritis[J]. Rheumatology (Oxford), 2002, 41(1): 103-106. DOI: 10.1093/rheumatology/41.1.103.
2.	Zaldivar Villon MLF, de la Rocha JAL, Espinoza LR. Takayasu arteritis: recent developments[J/OL]. Curr Rheumatol Rep, 2019, 21(9): 45[2019-07-18].https://pubmed.ncbi.nlm.nih.gov/31321560/. DOI: 10.1007/s11926-019-0848-3.
3.	Singh RB, Saini C, Shergill S, et al. Window to the circulatory system: ocular manifestations of cardiovascular diseases[J]. Eur J Ophthalmol, 2020, 30(6): 1207-1219. DOI: 10.1177/1120672120914232.
4.	Larrazabal RB, Chiu HHC, Magbitang-Santiago AT. Takayasu arteritis presenting as bilateral ocular ischemic syndrome[J]. Vasc Specialist Int, 2020, 36(3): 163-169. DOI: 10.5758/vsi.200031.
5.	Kannan NB, Kohli P, Ramachandran NO. Abnormal retinal vasculature in a young child: a diagnostic dilemma[J]. Ocul Immunol Inflamm, 2019, 29(1): 175-178. DOI: 10.1080/09273948.2019.1672199.
6.	Wong SPY, Mok CC, Lau CS, et al. Clinical presentation, treatment and outcome of Takayasu's arteritis in Southern Chinese: a multicenter retrospective study[J]. Rheumatol Int, 2018, 38(12): 2263-2270. DOI: 10.1007/s00296-018-4150-x.
7.	Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu arteritis observed from cross-country research in Japan: age and sex specificity[J]. Circulation, 2015, 132(18): 1701-1709. DOI: 10.1161/circulationaha.114.012547.
8.	Cilliers AM, Adams PE, Ntsinjana H, et al. Review of children with Takayasu’s arteritis at a Southern African tertiary care centre[J]. Cardiol Young, 2018, 28(9): 1129-1135. DOI: 10.1017/S1047951118000938.
9.	Cong XL, Dai SM, Feng X, et al. Takayasu's arteritis: clinical features and outcomes of 125 patients in China[J]. Clin Rheumatol, 2010, 29(9): 973-981. DOI: 10.1007/s10067-010-1496-1.
10.	Esen F, Ergelen R, Alibaz-Öner F, et al. Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study[J]. Br J Ophthalmol, 2019, 103(7): 928-932. DOI: 10.1136/bjophthalmol-2018-312580.
11.	Sagar S, Kar S, Gupta A, et al. Ocular changes in Takayasu's arteritis in India[J]. Jpn J Ophthalmol, 1994, 38(1): 97-102. DOI: 10.1007/BF00917835.
12.	Chun YS, Park SJ, Park IK, et al. The clinical and ocular manifestations of Takayasu arteritis[J]. Retina, 2001, 21(2): 132-140. DOI: 10.1097/00006982-200104000-00006.
13.	王伟伟, 叶俊杰, 陈有信, 等. 大动脉炎的眼底表现与治疗[J]. 中华眼科杂志, 2012, 48(2): 124-130. DOI: 10.3760/cma.j.issn.0412-4081.2012.02.007.Wang WW, Ye JJ, Chen YX, et al. Fundus manifestation and treatment of Takayasu's arteritis[J]. Chin J Ophthalmol, 2012, 48(2): 124-130. DOI: 10.3760/cma.j.issn.0412-4081.2012.02.007.
14.	Peter J, David S, Danda D, et al. Ocular manifestations of Takayasu arteritis: a cross-sectional study[J]. Retina, 2011, 31(6): 1170-1178. DOI: 10.1097/IAE.0b013e3181fe540b.
15.	Mirouse A, Biard L, Comarmond C, et al. Overall survival and mortality risk factors in Takayasu's arteritis: a multicenter study of 318 patients[J]. J Autoimmun, 2019, 96: 35-39. DOI: 10.1016/j.jaut.2018.08.001.
16.	Terelak-Borys B. Ocular ischemic syndrome-a systematic review[J]. Med Sci Monit, 2012, 18(8): 138-144. DOI: 10.12659/msm.883260.
17.	Font RL, Naumann G. Ocular histopathology in pulseless disease[J]. Arch Ophthalmol, 1969, 82(6): 784-788. DOI: 10.1001/archopht.1969.00990020776011.
18.	Christiansen ME, O'Carroll CB, Kumar G, et al. Transcranial doppler evaluation in Takayasu arteritis with oculo-cerebrovascular complications[J]. Neurologist, 2019, 24(1): 17-21. DOI: 10.1097/nrl.0000000000000202.
19.	Koz OG, Ates A, Numan Alp M, et al. Bilateral ocular ischemic syndrome as an initial manifestation of Takayasu's arteritis associated with carotid steal syndrome[J]. Rheumatol Int, 2007, 27(3): 299-302. DOI: 10.1007/s00296-006-0194-4.
20.	Gupta V, Luthra S, Shrinkhal N, et al. Takayasu's arteritis: a unique ophthalmic presentation with CRAO and BRVO[J/OL]. BMJ Case Rep, 2019, 12(8): e228909[2019-08-20]. https://pubmed.ncbi.nlm.nih.gov/31420422/. DOI: 10.1136/bcr-2018-228909.
21.	Noel N, Butel N, Le Hoang P, et al. Small vessel involvement in Takayasu’s arteritis[J]. Autoimmun Rev, 2013, 12(3): 355-362. DOI: 10.1016/j.autrev.2012.05.010.
22.	Russo RAG, Katsicas MM. Takayasu arteritis[J/OL]. Front Pediatr, 2018, 6: 265[2018-09-24].https://pubmed.ncbi.nlm.nih.gov/30338248/. DOI: 10.3389/fped.2018.00265.
23.	Pallangyo P, Epafra E, Nicholaus P, et al. Bilateral ocular ischemia-induced blindness as a presenting manifestation of Takayasu arteritis: a case report[J/OL]. J Med Case Rep, 2017, 11(1): 153[2017-06-10]. https://pubmed.ncbi.nlm.nih.gov/28599682/. DOI: 10.1186/s13256-017-1330-3.
24.	Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome[J]. Surv Ophthalmol, 2010, 55(1): 2-34. DOI: 10.1016/j.survophthal.2009.02.024.
25.	Reddy S, Tyagi M, Suresh A, et al. Multimodal imaging in bilateral ocular ischaemic syndrome with anterior ischaemic optic neuropathy in a case of Takayasu arteritis[J/OL]. BMJ Case Rep, 2020, 13(6): e236351[2020-06-28]. https://pubmed.ncbi.nlm.nih.gov/32595122/. DOI: 10.1136/bcr-2020-236351.
26.	Esatoglu SN, Ok AM, Ucar D, et al. Takayasu's arteritis: associated inflammatory diseases[J]. Clin Exp Rheumatol, 2020, 38 Suppl 124(2): S61-68.
27.	Padhy SK, Chawla R. Novel ultrawide field fundus fluorescein angiographic findings in a patient of Takayasu arteritis on immunosuppression[J]. Indian J Ophthalmol, 2020, 68(1): 238-240. DOI: 10.4103/ijo.IJO_455_19.
28.	Flores-Suarez L, Simon J, Reyes P, et al. Takayasu's arteritis presenting as bilateral cataracts: report of three cases[J]. Rheumatology (Oxford), 2003, 42(8): 1005-1007. DOI: 10.1093/rheumatology/keg244.
29.	Zhou B, Ye P, Wei S. Preliminary clinical analysis of neovascular glaucoma secondary to carotid artery disease[J]. Clin Exp Optom, 2011, 94(2): 207-211. DOI: 10.1111/j.1444-0938.2010.00555.x.
30.	Chotard G, Diwo E, Coscas F, et al. Fluorescein and OCT angiography features of Takayasu disease[J]. Ocul Immunol Inflamm, 2019, 27(5): 774-780. DOI: 10.1080/09273948.2018.1455876.
31.	Stamatis P. Giant cell arteritis versus Takayasu arteritis: an update[J]. Mediterr J Rheumatol, 2020, 31(2): 174-182. DOI: 10.31138/mjr.31.2.174.
32.	Gong Q, Qian T, Chen F, et al. A case of anti-VEGF therapy application in Takayasu arteries with retinopathy[J/OL]. Am J Ophthalmol Case Rep, 2020, 19: 100706[2020-09-15]. https://pubmed.ncbi.nlm.nih.gov/32923739/. DOI: 10.1016/j.ajoc.2020.100706.
33.	苏莉, 黄厚斌. 15例多发性大动脉炎眼底观察[J]. 中华眼视光学与视觉科学杂志, 2014, 16(12): 757-761. DOI: 10.3760/cma.j.issn.1674-845X.2014.12.013.Su L, Huang HB. Clinical analysis of ocular fundus change in 15 cases Takayasu arteritis[J]. Chin J Optom Ophthalmol Vis Sci, 2014, 16(12): 757-761. DOI: 10.3760/cma.j.issn.1674-845X.2014.12.013.
34.	Uyama M, Asayama K. Retinal vascular changes in Takayasu disease (pulseless disease), occurrence and evaluation of the lesion[J]. Doc Ophthalmol Proc Ser, 1976, 9: 549-554. DOI: 10.1007/978-94-010-1573-8_78.
35.	Kiyosawa M, Baba T. Ophthalmological findings in patients with Takayasu disease[J]. Int J Cardiol, 1998, 66(Suppl 1): S141-147. DOI: 10.1016/s0167-5273(98)00162-4.
36.	Bajgai P, Singh R. Retinal vasculitis in Takayasu's arteritis[J/OL]. N Engl J Med, 2018, 378(21): e28[2018-05-24]. https://pubmed.ncbi.nlm.nih.gov/29791818/. DOI: 10.1056/NEJMicm1711036.
37.	张健, 戴荣平, 陈有信, 等. 大动脉炎患者的荧光素眼底血管造影分析[J]. 眼科研究, 2010, 28(2): 153-156. DOI: 10.3969/j.issn.1003-0808.2010.02.014.Zhang J, Dai RP, Chen YX, et al. Clinical analysis of fundus fluorescein angiography in Takayasu arteritis[J]. Chin Ophthal Res, 2010, 28(2): 153-156. DOI: 10.3969/j.issn.1003-0808.2010.02.014.
38.	Matos KT, Arantes T, Souza AW, et al. Retinal angiography and colour Doppler of retrobulbar vessels in Takayasu arteritis[J]. Can J Ophthalmol, 2014, 49(1): 80-86. DOI: 10.1016/j.jcjo.2013.09.014.
39.	Tani T, Takahashi A, Nagaoka T, et al. Abnormality of retinal arterial velocity profiles using Doppler Fourier-domain optical coherence tomography in a case of Takayasu's arteritis with aortic regurgitation[J]. Am J Ophthalmol Case Rep, 2016, 5: 134-136. DOI: 10.1016/j.ajoc.2016.12.020.
40.	Sugiyama K, Ijiri S, Tagawa S, et al. Takayasu disease on the centenary of its discovery[J]. Jpn J Ophthalmol, 2009, 53(2): 81-91. DOI: 10.1007/s10384-009-0650-2.
41.	Arend WP, Michel BA, Bloch DA, et al. The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis[J]. Arthritis Rheum, 1990, 33(8): 1129-1134. DOI: 10.1002/art.1780330811.
42.	Hellmich B, Agueda A, Monti S, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis[J]. Ann Rheum Dis, 2020, 79(1): 19-30. DOI: 10.1136/annrheumdis-2019-215672.
43.	Sakthiswary R, Syazarina SO, Shaharir SS, et al. Blindness in a pulseless young woman: lessons learned[J]. Ocul Immunol Inflamm, 2012, 20(4): 309-311. DOI: 10.3109/09273948.2012.690491.
44.	Matsumoto-Otake A, Hirota K, Koto T, et al. Thickened retinal ganglion cell complex in patient with severe Takayasu retinopathy at early stage[J]. Retin Cases Brief Rep, 2015, 9(1): 41-44. DOI: 10.1097/icb.0000000000000073.
45.	Mason JC. Surgical intervention and its role in Takayasu arteritis[J]. Best Pract Res Clin Rheumatol, 2018, 32(1): 112-124. DOI: 10.1016/j.berh.2018.07.008.
46.	Dogra M, Kumar A, Bajgai P, et al. Outcome of endovascular procedures on ocular findings in Takayasu arteritis[J]. Retina, 2019, 39(6): 1142-1148. DOI: 10.1097/iae.0000000000002103.
47.	Subirà O, Muñoz S, Sánchez JJ, et al. Painless bilateral visual loss in a 33-year-old woman with severe arterial hypotension[J]. Surv Ophthalmol, 2018, 63(1): 125-131. DOI: 10.1016/j.survophthal.2017.03.001.
48.	Pelegrín L, Mesquida M, Rey A, et al. Blind runner[J]. Surv Ophthalmol, 2012, 57(5): 486-494. DOI: 10.1016/j.survophthal.2011.06.004.
49.	Demir MN, Hazirolan D, Altiparmak UE, et al. Takayasu's disease and secondary ocular ischemic syndrome[J]. J Pediatr Ophthalmol Strabismus, 2010, 47(1): 54-57. DOI: 10.3928/01913913-20100106-13.
50.	Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors[J]. Circulation, 1994, 90(4): 1855-1860. DOI: 10.1161/01.cir.90.4.1855.

1. Numano F. The story of Takayasu arteritis[J]. Rheumatology (Oxford), 2002, 41(1): 103-106. DOI: 10.1093/rheumatology/41.1.103.
2. Zaldivar Villon MLF, de la Rocha JAL, Espinoza LR. Takayasu arteritis: recent developments[J/OL]. Curr Rheumatol Rep, 2019, 21(9): 45[2019-07-18].https://pubmed.ncbi.nlm.nih.gov/31321560/. DOI: 10.1007/s11926-019-0848-3.
3. Singh RB, Saini C, Shergill S, et al. Window to the circulatory system: ocular manifestations of cardiovascular diseases[J]. Eur J Ophthalmol, 2020, 30(6): 1207-1219. DOI: 10.1177/1120672120914232.
4. Larrazabal RB, Chiu HHC, Magbitang-Santiago AT. Takayasu arteritis presenting as bilateral ocular ischemic syndrome[J]. Vasc Specialist Int, 2020, 36(3): 163-169. DOI: 10.5758/vsi.200031.
5. Kannan NB, Kohli P, Ramachandran NO. Abnormal retinal vasculature in a young child: a diagnostic dilemma[J]. Ocul Immunol Inflamm, 2019, 29(1): 175-178. DOI: 10.1080/09273948.2019.1672199.
6. Wong SPY, Mok CC, Lau CS, et al. Clinical presentation, treatment and outcome of Takayasu's arteritis in Southern Chinese: a multicenter retrospective study[J]. Rheumatol Int, 2018, 38(12): 2263-2270. DOI: 10.1007/s00296-018-4150-x.
7. Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu arteritis observed from cross-country research in Japan: age and sex specificity[J]. Circulation, 2015, 132(18): 1701-1709. DOI: 10.1161/circulationaha.114.012547.
8. Cilliers AM, Adams PE, Ntsinjana H, et al. Review of children with Takayasu’s arteritis at a Southern African tertiary care centre[J]. Cardiol Young, 2018, 28(9): 1129-1135. DOI: 10.1017/S1047951118000938.
9. Cong XL, Dai SM, Feng X, et al. Takayasu's arteritis: clinical features and outcomes of 125 patients in China[J]. Clin Rheumatol, 2010, 29(9): 973-981. DOI: 10.1007/s10067-010-1496-1.
10. Esen F, Ergelen R, Alibaz-Öner F, et al. Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study[J]. Br J Ophthalmol, 2019, 103(7): 928-932. DOI: 10.1136/bjophthalmol-2018-312580.
11. Sagar S, Kar S, Gupta A, et al. Ocular changes in Takayasu's arteritis in India[J]. Jpn J Ophthalmol, 1994, 38(1): 97-102. DOI: 10.1007/BF00917835.
12. Chun YS, Park SJ, Park IK, et al. The clinical and ocular manifestations of Takayasu arteritis[J]. Retina, 2001, 21(2): 132-140. DOI: 10.1097/00006982-200104000-00006.
13. 王伟伟, 叶俊杰, 陈有信, 等. 大动脉炎的眼底表现与治疗[J]. 中华眼科杂志, 2012, 48(2): 124-130. DOI: 10.3760/cma.j.issn.0412-4081.2012.02.007.Wang WW, Ye JJ, Chen YX, et al. Fundus manifestation and treatment of Takayasu's arteritis[J]. Chin J Ophthalmol, 2012, 48(2): 124-130. DOI: 10.3760/cma.j.issn.0412-4081.2012.02.007.
14. Peter J, David S, Danda D, et al. Ocular manifestations of Takayasu arteritis: a cross-sectional study[J]. Retina, 2011, 31(6): 1170-1178. DOI: 10.1097/IAE.0b013e3181fe540b.
15. Mirouse A, Biard L, Comarmond C, et al. Overall survival and mortality risk factors in Takayasu's arteritis: a multicenter study of 318 patients[J]. J Autoimmun, 2019, 96: 35-39. DOI: 10.1016/j.jaut.2018.08.001.
16. Terelak-Borys B. Ocular ischemic syndrome-a systematic review[J]. Med Sci Monit, 2012, 18(8): 138-144. DOI: 10.12659/msm.883260.
17. Font RL, Naumann G. Ocular histopathology in pulseless disease[J]. Arch Ophthalmol, 1969, 82(6): 784-788. DOI: 10.1001/archopht.1969.00990020776011.
18. Christiansen ME, O'Carroll CB, Kumar G, et al. Transcranial doppler evaluation in Takayasu arteritis with oculo-cerebrovascular complications[J]. Neurologist, 2019, 24(1): 17-21. DOI: 10.1097/nrl.0000000000000202.
19. Koz OG, Ates A, Numan Alp M, et al. Bilateral ocular ischemic syndrome as an initial manifestation of Takayasu's arteritis associated with carotid steal syndrome[J]. Rheumatol Int, 2007, 27(3): 299-302. DOI: 10.1007/s00296-006-0194-4.
20. Gupta V, Luthra S, Shrinkhal N, et al. Takayasu's arteritis: a unique ophthalmic presentation with CRAO and BRVO[J/OL]. BMJ Case Rep, 2019, 12(8): e228909[2019-08-20]. https://pubmed.ncbi.nlm.nih.gov/31420422/. DOI: 10.1136/bcr-2018-228909.
21. Noel N, Butel N, Le Hoang P, et al. Small vessel involvement in Takayasu’s arteritis[J]. Autoimmun Rev, 2013, 12(3): 355-362. DOI: 10.1016/j.autrev.2012.05.010.
22. Russo RAG, Katsicas MM. Takayasu arteritis[J/OL]. Front Pediatr, 2018, 6: 265[2018-09-24].https://pubmed.ncbi.nlm.nih.gov/30338248/. DOI: 10.3389/fped.2018.00265.
23. Pallangyo P, Epafra E, Nicholaus P, et al. Bilateral ocular ischemia-induced blindness as a presenting manifestation of Takayasu arteritis: a case report[J/OL]. J Med Case Rep, 2017, 11(1): 153[2017-06-10]. https://pubmed.ncbi.nlm.nih.gov/28599682/. DOI: 10.1186/s13256-017-1330-3.
24. Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome[J]. Surv Ophthalmol, 2010, 55(1): 2-34. DOI: 10.1016/j.survophthal.2009.02.024.
25. Reddy S, Tyagi M, Suresh A, et al. Multimodal imaging in bilateral ocular ischaemic syndrome with anterior ischaemic optic neuropathy in a case of Takayasu arteritis[J/OL]. BMJ Case Rep, 2020, 13(6): e236351[2020-06-28]. https://pubmed.ncbi.nlm.nih.gov/32595122/. DOI: 10.1136/bcr-2020-236351.
26. Esatoglu SN, Ok AM, Ucar D, et al. Takayasu's arteritis: associated inflammatory diseases[J]. Clin Exp Rheumatol, 2020, 38 Suppl 124(2): S61-68.
27. Padhy SK, Chawla R. Novel ultrawide field fundus fluorescein angiographic findings in a patient of Takayasu arteritis on immunosuppression[J]. Indian J Ophthalmol, 2020, 68(1): 238-240. DOI: 10.4103/ijo.IJO_455_19.
28. Flores-Suarez L, Simon J, Reyes P, et al. Takayasu's arteritis presenting as bilateral cataracts: report of three cases[J]. Rheumatology (Oxford), 2003, 42(8): 1005-1007. DOI: 10.1093/rheumatology/keg244.
29. Zhou B, Ye P, Wei S. Preliminary clinical analysis of neovascular glaucoma secondary to carotid artery disease[J]. Clin Exp Optom, 2011, 94(2): 207-211. DOI: 10.1111/j.1444-0938.2010.00555.x.
30. Chotard G, Diwo E, Coscas F, et al. Fluorescein and OCT angiography features of Takayasu disease[J]. Ocul Immunol Inflamm, 2019, 27(5): 774-780. DOI: 10.1080/09273948.2018.1455876.
31. Stamatis P. Giant cell arteritis versus Takayasu arteritis: an update[J]. Mediterr J Rheumatol, 2020, 31(2): 174-182. DOI: 10.31138/mjr.31.2.174.
32. Gong Q, Qian T, Chen F, et al. A case of anti-VEGF therapy application in Takayasu arteries with retinopathy[J/OL]. Am J Ophthalmol Case Rep, 2020, 19: 100706[2020-09-15]. https://pubmed.ncbi.nlm.nih.gov/32923739/. DOI: 10.1016/j.ajoc.2020.100706.
33. 苏莉, 黄厚斌. 15例多发性大动脉炎眼底观察[J]. 中华眼视光学与视觉科学杂志, 2014, 16(12): 757-761. DOI: 10.3760/cma.j.issn.1674-845X.2014.12.013.Su L, Huang HB. Clinical analysis of ocular fundus change in 15 cases Takayasu arteritis[J]. Chin J Optom Ophthalmol Vis Sci, 2014, 16(12): 757-761. DOI: 10.3760/cma.j.issn.1674-845X.2014.12.013.
34. Uyama M, Asayama K. Retinal vascular changes in Takayasu disease (pulseless disease), occurrence and evaluation of the lesion[J]. Doc Ophthalmol Proc Ser, 1976, 9: 549-554. DOI: 10.1007/978-94-010-1573-8_78.
35. Kiyosawa M, Baba T. Ophthalmological findings in patients with Takayasu disease[J]. Int J Cardiol, 1998, 66(Suppl 1): S141-147. DOI: 10.1016/s0167-5273(98)00162-4.
36. Bajgai P, Singh R. Retinal vasculitis in Takayasu's arteritis[J/OL]. N Engl J Med, 2018, 378(21): e28[2018-05-24]. https://pubmed.ncbi.nlm.nih.gov/29791818/. DOI: 10.1056/NEJMicm1711036.
37. 张健, 戴荣平, 陈有信, 等. 大动脉炎患者的荧光素眼底血管造影分析[J]. 眼科研究, 2010, 28(2): 153-156. DOI: 10.3969/j.issn.1003-0808.2010.02.014.Zhang J, Dai RP, Chen YX, et al. Clinical analysis of fundus fluorescein angiography in Takayasu arteritis[J]. Chin Ophthal Res, 2010, 28(2): 153-156. DOI: 10.3969/j.issn.1003-0808.2010.02.014.
38. Matos KT, Arantes T, Souza AW, et al. Retinal angiography and colour Doppler of retrobulbar vessels in Takayasu arteritis[J]. Can J Ophthalmol, 2014, 49(1): 80-86. DOI: 10.1016/j.jcjo.2013.09.014.
39. Tani T, Takahashi A, Nagaoka T, et al. Abnormality of retinal arterial velocity profiles using Doppler Fourier-domain optical coherence tomography in a case of Takayasu's arteritis with aortic regurgitation[J]. Am J Ophthalmol Case Rep, 2016, 5: 134-136. DOI: 10.1016/j.ajoc.2016.12.020.
40. Sugiyama K, Ijiri S, Tagawa S, et al. Takayasu disease on the centenary of its discovery[J]. Jpn J Ophthalmol, 2009, 53(2): 81-91. DOI: 10.1007/s10384-009-0650-2.
41. Arend WP, Michel BA, Bloch DA, et al. The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis[J]. Arthritis Rheum, 1990, 33(8): 1129-1134. DOI: 10.1002/art.1780330811.
42. Hellmich B, Agueda A, Monti S, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis[J]. Ann Rheum Dis, 2020, 79(1): 19-30. DOI: 10.1136/annrheumdis-2019-215672.
43. Sakthiswary R, Syazarina SO, Shaharir SS, et al. Blindness in a pulseless young woman: lessons learned[J]. Ocul Immunol Inflamm, 2012, 20(4): 309-311. DOI: 10.3109/09273948.2012.690491.
44. Matsumoto-Otake A, Hirota K, Koto T, et al. Thickened retinal ganglion cell complex in patient with severe Takayasu retinopathy at early stage[J]. Retin Cases Brief Rep, 2015, 9(1): 41-44. DOI: 10.1097/icb.0000000000000073.
45. Mason JC. Surgical intervention and its role in Takayasu arteritis[J]. Best Pract Res Clin Rheumatol, 2018, 32(1): 112-124. DOI: 10.1016/j.berh.2018.07.008.
46. Dogra M, Kumar A, Bajgai P, et al. Outcome of endovascular procedures on ocular findings in Takayasu arteritis[J]. Retina, 2019, 39(6): 1142-1148. DOI: 10.1097/iae.0000000000002103.
47. Subirà O, Muñoz S, Sánchez JJ, et al. Painless bilateral visual loss in a 33-year-old woman with severe arterial hypotension[J]. Surv Ophthalmol, 2018, 63(1): 125-131. DOI: 10.1016/j.survophthal.2017.03.001.
48. Pelegrín L, Mesquida M, Rey A, et al. Blind runner[J]. Surv Ophthalmol, 2012, 57(5): 486-494. DOI: 10.1016/j.survophthal.2011.06.004.
49. Demir MN, Hazirolan D, Altiparmak UE, et al. Takayasu's disease and secondary ocular ischemic syndrome[J]. J Pediatr Ophthalmol Strabismus, 2010, 47(1): 54-57. DOI: 10.3928/01913913-20100106-13.
50. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors[J]. Circulation, 1994, 90(4): 1855-1860. DOI: 10.1161/01.cir.90.4.1855.

Previous Article
A review of advances in biologic therapy for Behçet uveitis

Chinese Journal of Ocular Fundus Diseases

Recent advances in the diagnosis and management of Takayasu arteritis complicated with ocular ischemic syndrome

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content